The Pennant Group (PNTG) Competitors $23.64 -0.27 (-1.13%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$23.64 0.00 (0.00%) As of 10/17/2025 04:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PNTG vs. PRVA, HTFL, VCYT, CON, SGRY, GRAL, ADUS, ARDT, LFST, and CELCShould you be buying The Pennant Group stock or one of its competitors? The main competitors of The Pennant Group include Privia Health Group (PRVA), Heartflow (HTFL), Veracyte (VCYT), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), GRAIL (GRAL), Addus HomeCare (ADUS), Ardent Health (ARDT), LifeStance Health Group (LFST), and Celcuity (CELC). These companies are all part of the "healthcare" industry. The Pennant Group vs. Its Competitors Privia Health Group Heartflow Veracyte Concentra Group Holdings Parent Surgery Partners GRAIL Addus HomeCare Ardent Health LifeStance Health Group Celcuity Privia Health Group (NASDAQ:PRVA) and The Pennant Group (NASDAQ:PNTG) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends. Does the media prefer PRVA or PNTG? In the previous week, The Pennant Group had 4 more articles in the media than Privia Health Group. MarketBeat recorded 5 mentions for The Pennant Group and 1 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.58 beat The Pennant Group's score of -0.18 indicating that Privia Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive The Pennant Group 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher valuation & earnings, PRVA or PNTG? The Pennant Group has lower revenue, but higher earnings than Privia Health Group. The Pennant Group is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrivia Health Group$1.74B1.80$14.39M$0.11232.09The Pennant Group$695.24M1.18$22.56M$0.7830.31 Which has more risk and volatility, PRVA or PNTG? Privia Health Group has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, The Pennant Group has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500. Is PRVA or PNTG more profitable? The Pennant Group has a net margin of 3.36% compared to Privia Health Group's net margin of 0.78%. The Pennant Group's return on equity of 9.85% beat Privia Health Group's return on equity.Company Net Margins Return on Equity Return on Assets Privia Health Group0.78% 2.13% 1.25% The Pennant Group 3.36%9.85%4.04% Do analysts recommend PRVA or PNTG? Privia Health Group presently has a consensus target price of $28.91, indicating a potential upside of 13.24%. The Pennant Group has a consensus target price of $34.40, indicating a potential upside of 45.52%. Given The Pennant Group's higher possible upside, analysts plainly believe The Pennant Group is more favorable than Privia Health Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Privia Health Group 1 Sell rating(s) 2 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.71The Pennant Group 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do insiders and institutionals believe in PRVA or PNTG? 94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 85.9% of The Pennant Group shares are owned by institutional investors. 10.7% of Privia Health Group shares are owned by insiders. Comparatively, 5.4% of The Pennant Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryPrivia Health Group and The Pennant Group tied by winning 8 of the 16 factors compared between the two stocks. Get The Pennant Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PNTG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PNTG vs. The Competition Export to ExcelMetricThe Pennant GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$826.38M$4.24B$6.10B$10.50BDividend YieldN/A1.25%5.73%4.81%P/E Ratio30.3130.1684.5227.09Price / Sales1.18287.67611.79219.27Price / Cash25.9328.2037.1661.22Price / Book2.604.7712.246.52Net Income$22.56M$197.51M$3.32B$276.75M7 Day Performance-2.92%4.86%1.25%2.00%1 Month Performance-4.52%5.00%6.28%2.26%1 Year Performance-32.17%28.02%59.92%35.58% The Pennant Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PNTGThe Pennant Group3.7408 of 5 stars$23.64-1.1%$34.40+45.5%-32.8%$826.38M$695.24M30.317,000Analyst ForecastShort Interest ↑PRVAPrivia Health Group2.9221 of 5 stars$24.14+0.2%$28.91+19.8%+38.4%$2.96B$1.74B219.471,140HTFLHeartflowN/A$33.22-0.7%$36.60+10.2%N/A$2.79BN/A0.00699VCYTVeracyte3.8884 of 5 stars$34.09-2.0%$40.90+20.0%+4.4%$2.74B$445.76M103.31790News CoverageCONConcentra Group Holdings Parent2.5159 of 5 stars$20.17-0.7%$27.75+37.6%-5.8%$2.60B$1.90B16.9511,250SGRYSurgery Partners3.6222 of 5 stars$19.79+0.3%$31.14+57.4%-37.7%$2.53B$3.11B-13.8415,000GRALGRAIL0.5814 of 5 stars$70.44+6.5%$56.67-19.6%+449.3%$2.38B$125.60M-5.371,360Trending NewsInsider TradeADUSAddus HomeCare4.8085 of 5 stars$112.58-0.3%$137.50+22.1%-11.1%$2.08B$1.15B24.8549,703Positive NewsARDTArdent Health3.6678 of 5 stars$14.10+0.4%$19.30+36.9%-24.8%$2.01B$5.97B7.7924,900News CoverageAnalyst ForecastLFSTLifeStance Health Group3.3701 of 5 stars$5.11+1.2%$8.50+66.3%-30.1%$1.96B$1.25B-102.2010,218News CoverageCELCCelcuity2.5324 of 5 stars$47.41+2.9%$56.50+19.2%+236.3%$1.95BN/A-13.7440News CoverageAnalyst UpgradeGap Down Related Companies and Tools Related Companies PRVA Competitors HTFL Competitors VCYT Competitors CON Competitors SGRY Competitors GRAL Competitors ADUS Competitors ARDT Competitors LFST Competitors CELC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PNTG) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredThe Truth about AI Stocks’ Money MachineBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Pennant Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share The Pennant Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PNTG Stock Alerts